Synthesis and biological evaluation of 12-N-p-chlorobenzyl sophoridinol derivatives as a novel family of anticancer agents

Add time:07/21/2019    Source:sciencedirect.com

Taking 12-N-p-chlorobenzyl sophoridinol 2 as a lead, a series of novel sophoridinic derivatives with various 3′-substituents at the 11–side chain were synthesized and evaluated for their anticancer activity from sophoridine (1), a natural antitumor medicine. Among them, the sophoridinic ketones 5a–b, alkenes 7a–b and sophoridinic amines 14a–b displayed reasonable antiproliferative activity with IC50 values ranging from 3.8 to 5.4 μmol/L. Especially, compounds 5a and 7b exhibited an equipotency in both adriamycin (AMD)-susceptible and resistant MCF-7 breast carcinoma cells, indicating a different mechanism from AMD. The primary mechanism of action of 5a was to arrest the cell cycle at the G0/G1 phase, consistent with that of parent compound 1. Thus, we consider 12-chlorobenzyl sophoridinic derivatives with a tricyclic scaffold to be a new class of promising antitumor agents with an advantage of inhibiting drug-resistant cancer cells.

We also recommend Trading Suppliers and Manufacturers of N-(2-CHLOROBENZYL)-1-BUTANAMINE HYDROCHLORIDE (cas 16183-40-7). Pls Click Website Link as below: cas 16183-40-7 suppliers

Prev:A comparative assessment of metals and phthalates in commercial tea infusions: A starting point to evaluate their tolerance limits
Next:Evaluation of antihypertensive effects of S.9-390 (2-(o-chlorobenzyl) imidazoline hydrochloride))